Published ahead of print on September 11, 2003, doi:10.1165/rcmb.2003-0059OC
© 2004 American Thoracic Society DOI: 10.1165/rcmb.2003-0059OC Alveolar Macrophages from HIV-Infected Subjects are Resistant to Mycobacterium tuberculosis In VitroDivision of Pulmonary/Critical Care Medicine, Department of Medicine, Indiana University Medical Center, Indianapolis, Indiana Address correspondence to: Homer L. Twigg III, M.D., Indiana University Medical Center, 1481 West 10th St., 111P-IU, Indianapolis, IN 46202. E-mail: htwig{at}iupui.edu
HIV-infected individuals frequently develop Mycobacterium tuberculosis (MTB) infection. Alveolar macrophages (AM) are the initial host defense against this organism. We measured MTB growth in AM from normal and HIV-infected subjects after in vitro exposure. Intracellular growth of MTB was reduced in AM from HIV-infected subjects compared with normal macrophages. This was confined to subjects with CD4 counts greater than 200/µl. Growth of avirulent mycobacteria in HIV macrophages was significantly less than virulent MTB. Because avirulent MTB is more sensitive to tumor necrosis factor-
Abbreviations: alveolar macrophages, AM bronchoalveolar lavage, BAL enzyme-linked immunosorbent assay, ELISA fluorescein isothiocyanate, FITC monocytes, Mo Mycobacterium tuberculosis, MTB peripheral blood mononuclear cells, PBMCs phosphate-buffered saline, PBS tumor necrosis factor- This article has been cited by other articles:
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||